AI assistant
CONMED Corp — Director's Dealing 2021
Nov 5, 2021
31971_dirs_2021-11-05_cef62821-18a7-40a1-8e16-246d0004ec00.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2021-11-03
Reporting Person: Beyer Pat (President Int'l & Global Ortho)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-03 | Common Stock | S | 400 | $147.505 | Disposed | 24854 | Direct |
| 2021-11-03 | Common Stock | S | 10550 | $148.472 | Disposed | 14304 | Direct |
| 2021-11-03 | Common Stock | S | 6497 | $149.199 | Disposed | 7807 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.95 to $147.92. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.00 to $148.92. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.02 to $149.52. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.